All Stories

  1. Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy

    Article • European Respiratory Journal, December 2018, European Respiratory Society (ERS)

    Dr Xiaodong Zhao, baohui han

  2. Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy

    Article • Technology in Cancer Research & Treatment, January 2018, SAGE Publications

    baohui han

  3. Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

    Article • Cancer Biology and Medicine, January 2018, Tsinghua University Press

    baohui han